133 related articles for article (PubMed ID: 29205119)
1. Activity of Rifabutin and Hemi-synthetic Derivatives Against Mycobacterium abscessus.
Ramis IB; Figueiredo R; Ramos DF; Halicki PCB; von Groll A; Viveiros M; do Ceu Costa M; da Silva PEA
Med Chem; 2018; 14(4):394-399. PubMed ID: 29205119
[TBL] [Abstract][Full Text] [Related]
2. Rifabutin Is Bactericidal against Intracellular and Extracellular Forms of Mycobacterium abscessus.
Johansen MD; Daher W; Roquet-Banères F; Raynaud C; Alcaraz M; Maurer FP; Kremer L
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816730
[No Abstract] [Full Text] [Related]
3.
Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
[TBL] [Abstract][Full Text] [Related]
4. Rifabutin Is Active against Mycobacterium abscessus Complex.
Aziz DB; Low JL; Wu ML; Gengenbacher M; Teo JWP; Dartois V; Dick T
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396540
[TBL] [Abstract][Full Text] [Related]
5. Rifabutin Is Active against Mycobacterium abscessus in Mice.
Dick T; Shin SJ; Koh WJ; Dartois V; Gengenbacher M
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767722
[TBL] [Abstract][Full Text] [Related]
6. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
Pryjma M; Burian J; Thompson CJ
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
[No Abstract] [Full Text] [Related]
7.
Le Run E; Arthur M; Mainardi JL
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866869
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of rifabutin against Mycobacterium abscessus, clinical isolates.
Chen J; Zhang H; Guo Q; He S; Xu L; Zhang Z; Ma J; Chu H
Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):767-775. PubMed ID: 35531776
[TBL] [Abstract][Full Text] [Related]
9. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
[TBL] [Abstract][Full Text] [Related]
10.
Le Run E; Arthur M; Mainardi JL
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745387
[No Abstract] [Full Text] [Related]
11. Differential
Lee J; Ammerman N; Agarwal A; Naji M; Li SY; Nuermberger E
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168614
[TBL] [Abstract][Full Text] [Related]
12. Rifabutin Is Inactivated by Mycobacterium abscessus Arr.
Schäfle D; Selchow P; Borer B; Meuli M; Rominski A; Schulthess B; Sander P
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318008
[No Abstract] [Full Text] [Related]
13. Determination of the Critical Concentration of Rifabutin for Susceptibility Testing Using the Proportion Method with Löwenstein-Jensen Medium against Mycobacterium Tuberculosis Isolates.
Dai G; Chen S; Dong L; Li YX; Huo F; Shang Y; Huang H
Lab Med; 2019 Jul; 50(3):292-297. PubMed ID: 30806669
[TBL] [Abstract][Full Text] [Related]
14. Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori.
Suzuki S; Suzuki H; Nishizawa T; Kaneko F; Ootani S; Muraoka H; Saito Y; Kobayashi I; Hibi T
Digestion; 2009; 79(1):1-4. PubMed ID: 19142036
[TBL] [Abstract][Full Text] [Related]
15. Blocking Bacterial Naphthohydroquinone Oxidation and ADP-Ribosylation Improves Activity of Rifamycins against Mycobacterium abscessus.
Ganapathy US; Lan T; Krastel P; Lindman M; Zimmerman MD; Ho H; Sarathy JP; Evans JC; Dartois V; Aldrich CC; Dick T
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0097821. PubMed ID: 34228543
[TBL] [Abstract][Full Text] [Related]
16. Rifamycin O, An Alternative Anti-
Hanh BTB; Park JW; Kim TH; Kim JS; Yang CS; Jang K; Cui J; Oh DC; Jang J
Molecules; 2020 Mar; 25(7):. PubMed ID: 32244387
[No Abstract] [Full Text] [Related]
17. Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus.
Wang S; Cai X; Yu W; Zeng S; Zhang J; Guo L; Gao Y; Lu Z; Hameed HMA; Fang C; Tian X; Yusuf B; Chhotaray C; Alam MDS; Zhang B; Ge H; Maslov DA; Cook GM; Peng J; Lin Y; Zhong N; Zhang G; Zhang T
Microbiol Spectr; 2022 Aug; 10(4):e0276321. PubMed ID: 35946941
[TBL] [Abstract][Full Text] [Related]
18.
Fujiwara K; Aono A; Asami T; Morimoto K; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Mitarai S
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0157922. PubMed ID: 37154742
[TBL] [Abstract][Full Text] [Related]
19. Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.
Berrada ZL; Lin SY; Rodwell TC; Nguyen D; Schecter GF; Pham L; Janda JM; Elmaraachli W; Catanzaro A; Desmond E
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):177-81. PubMed ID: 27036978
[TBL] [Abstract][Full Text] [Related]
20. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.
Li B; Ye M; Guo Q; Zhang Z; Yang S; Ma W; Yu F; Chu H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
